Koyfin Home > Directory > Health Care > Akebia Therapeutics > Total Revenue

Akebia Therapeutics Total Revenue Chart (AKBA)

Akebia Therapeutics annual/quarterly Total Revenue from 2016 to 2020. Revenue is the money that a business receives from its normal business activities, usually from the sale of goods and services to customers.
  • Akebia Therapeutics Total Revenue for the quarter ending June 06, 2020 was $90m a -2.04% decrease of -2m year over year
  • Akebia Therapeutics Total Revenue for the last 12 months ending June 06, 2020 was $340m a 4.37% increase of 15m year over year
  • Akebia Therapeutics Annual Total Revenue for 2019 was $335m a 37.99% increase of 127m from 2018
  • Akebia Therapeutics Annual Total Revenue for 2018 was $208m a 12.76% increase of 27m from 2017
  • Akebia Therapeutics Annual Total Revenue for 2017 was $181m a 99.15% increase of 180m from 2016
Other Income Statement Metrics:
  • Akebia Therapeutics EBITDA for the quarter ending December 12, 2018 was $-85m a 71.45% decrease of -61m year over year
  • Akebia Therapeutics Net Income for the quarter ending December 12, 2018 was $-88m a 73.50% decrease of -65m year over year
View Chart On Koyfin

Quarterly AKBA Total Revenue Data

06/2020$90m
03/2020$88m
12/2019$70m
09/2019$92m
06/2019$101m
03/2019$73m
12/2018$60m
09/2018$53m
06/2018$49m
03/2018$46m

Annual AKBA Total Revenue Data

2019$335m
2018$208m
2017$181m
2016$2m